Literature DB >> 22892783

Exogenous ochronosis: case report and literature review.

Viviane Maria Rocha Martins1, Antônio Renê Diógenes de Sousa, Natália de Carvalho Portela, Celina Aguiar Frota Tigre, Lucidi Maria Saraiva Gonçalves, Rômulo José de Lucena Castro Filho.   

Abstract

Exogenous ochronosis is a rare, cosmetically disfiguring condition, resulting from the longterm use of topical hydroquinone in treatment of melasma. It manifests as gray-brown or blue-black macules in hydroquinone-exposed regions. The exact incidence of ochronosis is unknown. High rates have been reported in the South African population, and it is rare in the United States. We report the case of a patient who developed exogenous ochronosis while using topical hydroquinone. It is necessary to recognize this disorder at the earliest stage and discontinue hydroquinone immediately, as its treatment is difficult. Sun exposure facilitates the formation of exogenous ochronosis and must be strictly avoided, although it is a practical problem in the tropical climate of Brazil, particularly for those who work outdoors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22892783     DOI: 10.1590/s0365-05962012000400021

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  3 in total

1.  Adverse cutaneous reactions to skin care products on the face vary with age, but not with sex.

Authors:  Li-Ning Huang; Yi-Ping Zhong; Dan Liu; Xiao-Hua Wang; Can-Yi Gong; Si Wen; Peter M Elias; Bin Yang; Mao-Qiang Man
Journal:  Contact Dermatitis       Date:  2018-09-12       Impact factor: 6.600

2.  Exogenous Ochronosis (EO): Skin lightening cream causing rare caviar-like lesion with banana-like pigments; review of literature and histological comparison with endogenous counterpart.

Authors:  Amir Qorbani; Adnan Mubasher; George Peter Sarantopoulos; Scott Nelson; Maxwell Alexander Fung
Journal:  Autops Case Rep       Date:  2020-09-02

Review 3.  Exogenous Ochronosis.

Authors:  Prachi A Bhattar; Vijay P Zawar; Kiran V Godse; Sharmila P Patil; Nitin J Nadkarni; Manjyot M Gautam
Journal:  Indian J Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.